NANJING, China--(BUSINESS WIRE)-- With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.
217 companies from 13 countries and regions and over 8,000 professional visitors are expected to be present at the three days exhibition & conferences. Join us and take advantage of this unique business opportunity.
Below is a preview of some of our exhibitors. More information, please visit www.biotechchina-nj.com/en
Life Sciences Advanced Technologies Inc.
Life Sciences Advanced Technologies continues to build on the well-established biochemical product line we have manufactured and distributed since 1962. For almost fifty years, Life Sciences has been the world’s leading commercial producer of native AMV reverse transcriptase. Life Sciences has evolved into Life Sciences Advanced Technologies by building on its existing product line.
Life Sciences Advanced Technologies is committed to providing quality enzymes and biochemical products with an emphasis on service, value and customer satisfaction. We pride ourselves in striving to respond to your scientific needs with a sense of urgency and timeliness. Life Sciences has expanded our product line to meet the demands of the medical, scientific and research communities.
We are continuously collaborating with major pharmaceutical, biotechnology and research organizations to develop products that are impacting the global market. More specifically we have worked with companies, institutions, and individual research scientists to develop and improve products in PCR, enzyme modification, molecular diagnostic testing, immunology, and protein stability. Building on fifty years of scientific research experience, LSAT provides viable scientific knowledge to our clients and partners around the world.
Anteo Diagnostics Limited
Anteo Diagnostics Limited is a surface coating company with a proprietary family of metal complex-based enabling chemistries, called Mix&GoTM. The Mix&GoTM surface chemistry allows effective binding of proteins onto solid surfaces contributing to easy production of superior surfaces and faster product development for the biotechnology, diagnostics and pharmaceutical industries.
The company evolved from Bio-Layer, an Australian material science company established in 1999. In 2008, the Company was renamed Anteo Diagnostics, derived from the Latin word for “anticipate, prevent, precede”, reflecting the company’s approach to diagnostics opportunities.
Our Mix&GoTM technology is gaining traction with a wide spectrum of clients in the in vitro diagnostics industry including bead manufacturers, test developers, test manufacturers, and life science companies. So far Anteo Dx has entered into commercial licences with Life Technologies, Bangs Laboratories, Merck KGaA and eBioscience.
Anteo Dx is headquartered in a state-of-the art laboratory space in the Brisbane Technology Park, Brisbane, Australia.
JRI, the expert of control and monitoring systems
For over 160 years, JRI has manufactured and designed control and monitoring systems.
Recognized for the high quality performance, the models of the monitoring systems developed by JRI make it possible to control various parameters such as the temperature, the humidity, the pressure, the levels... and to answer the legal provisions as regards traceability.
BioAlps Association is the Life Sciences cluster from Western Switzerland. It is supported by the Cantons of Bern, Fribourg, Vaud, Neuchâtel, Geneva, Valais, Jura and the Swiss State Secretariat for Economic Affairs.
With a mission of promoting the excellence and performance in MedTech and BioTech developments in this cluster at all levels: regionally, nationally and in the international arena. BioAlps is the entry point to a wealth of contacts, knowhow, and knowledge, and provides both personal and institutional support.
BioAlps organises events and co organises conventions, participates in a number of international events and supports conferences promoting the cluster and offering its members a wealth of networking opportunities.
BioAlps is the world's most diversified life science cluster and one of the most dynamic. It comprises 780 companies, 20 academic institutions, 500 public and private laboratories, scientific parks, and incubator bodies active in the life science, representing 20,000 people and 5000 researchers.
BioAlps hosts during BIOTECH_2014 companies active in
- Therapeutics Products: oncology, immunology, infectious diseases, rheumatology and ophthalmology
- Regenerative medicine: Autologous Platelet Rich Plasma
- 3D Bio Printing and Biomaterials
- Bio-Dashboard Web Services
- Bioactive surface coating and medical parts micro engraving device
- Swiss-China Innovation, Research, Technology and Education networking
GREATER GENEVA BERNE area (GGBa)
GREATER GENEVA BERNE area (GGBa) is an Economic Development Agency complementary to BioAlps’s mission offering tailor-made solutions to the Biotech and Medtech industries wishing to develop activities in Western Switzerland
provides expert insight into the region’s different cultural and economic strengths and all the information needed by an enterprise to be a success in Switzerland.
offers time-saving support to international companies
brings company ideas to the market by finding industrial partners and helping negotiation with them
provide free, tailor-made assistance in all stages of the process, from evaluating suitable locations to finalizing
identifies suitable premises close to potential industrial/technological partners in Biotech and Medtech sectors
provides investment opportunities for small and medium-sized enterprises (SME) and start-up businesses
establishes networking opportunities for biotech and medtech industries facilitating their integration
Bio Dashboard is the place to get information, exchange, work, and promote online worldwide in Life Sciences for researchers, executives, business developers, marketers, media, students, etc.
Beyond a social network, Biowebspin offers unique adapted tools to Pharma, Biotech, and Medtech professionals in order to optimize and simplify their daily tasks at work.
Engagement: Biowebspin helps associations, guilds, valorization organizations, and professionals or future professionals around the world who have the will to promote Biosciences and help its actors. Special offers or partnerships would be offered.
Debiopharm International SA searches, evaluates and in-licenses promising drug candidates for development. Towards the end of the development process, the products are licensed out to pharmaceutical companies for world-wide marketing and sales.
The Company has successfully developed five products. These products include:
Eloxatin® for the treatment of colorectal cancer,
Decapeptyl®/Trelstar®/Pamorelin®/1-month, 3-month and 6-month formulations for the treatment of advanced prostate cancer, endometriosis, precocious puberty, in vitro fertilisation programmes, uterine fibroids, and
Moapar®/Salvacyl® for the treatment of severe sexual deviations.
In life science applications, DHM-T1000 provides precise Quantitative Phase Measurements (QPM) of living cell cultures up to confluence, without the use of any contrast agent and with very low illumination power. It is very sensitive to small morphology modifications, and to intra-cellular concentration changes. The DHM-T1000 is thus an ideal instrument for high-throughput screening, time lapse measurements and time monitoring. Used in conjunction with the optional fluorescence module, it enables simultaneous DHM and fluorescence measurements.
Bionano Gold coated glass slides: Gold thin films grown on microscope glass slides with Titanium adhesion layer.
Au(111) thin films on mica: Gold (111) epitaxial thin films grown on freshly cleaved mica substrates
R&D within PHASIS: PHASIS is involved in several applied research projects with both academic and industrial partners. PHASIS is interested in the use of new materials to bring new insights in the field of gas sensors. Moreover, the flexibility of PHASIS' equipment allows the production of thin films with tailored properties.
3D cellular constructs on-demand. Bottom-up fabrication of scaffolds-cell-constructs requires scaffold materials that can be controlled with regards to their microarchitecture but also chemical and physical properties. A Bio-printer with high resolution permits the spatial control of scaffold materials and also enables the deposition of cells in target areas.
Usage of smart biomaterials such as cellular components shows high promises to enter a new dimension to address actual unmet medical needs
Universal Matrix for 3D Tissue Printing. The BioInkTM is a semi-synthetic hydrogel supporting cell growth of different cell types (fibroblasts, keratinocytes, etc.) by providing cell adhesion sites and mimicking the natural extracellular matrix. The BioInkTM is provided as a ready-to-use device to print 3D tissues. Critical parameters such as matrix stiffness, cell adhesion can be tailored. Exclusively designed for BioFactory® and 3DDiscovery® tissue printers.
The ALL-IN-ONE Drug discovery liquid handling device. The 3DDiscovery® instrument is a multi-functional liquid handling device responding to today's requirements of 2D/3D Drug Discovery/Toxicology screening applications. The 3DDiscovery® instrument is both a powerful FLUID DISPENSER addressing today's industrial needs, as well as a three-dimensional BIOPRINTER responding to the upcoming challenges facing the pharmaceutical, biotech and clinical research organizations.
Application of Autologous Platelet Rich Plasma has been evaluated in various medical disciplines including orthopaedics, sports medicine, wound healing, neurosurgery, dentistry, ophthalmology as well as cosmetic, plastic, maxillofacial and cardiothoracic surgery.
The technology is processing the patient´s own blood, fat or bone marrow to use the concentrated cells.
Autologous Platelet Rich Plasma also contains fibrin, fibronectin and vitronectin that act as cell adhesion molecules for osteoconduction and as a matrix for bone, connective tissue and epithelial migration 4.
The Regen Extracell BMC technology and its products aim is to dramatically enhance tissue regeneration toward a quicker and more successful patient’s recovery. At the edge of the latest developments of the cellular therapy research, the Regen Extracell contribution in the world of orthopaedics wishes to be safe and realistic.
Swissnex - China
Swissnex is a network with nodes in the world's most innovative hubs, where the future is being shaped. We take an active role in strengthening Switzerland's leadership as a world-class location for science, education and innovation. Our core value lies in our ability to:
Strengthen Switzerland's profile as a nation of leading-edge research, quality, innovation and openness
Connect scientists, researchers, entrepreneurs, policy-makers and thought leaders with inspiring peers and new ideas on either side of the globe
Facilitate academic programs, global innovation strategies, and knowledge exchange
Create and present transdisciplinary projects in imaginative ways
Network with relevant contacts at universities, research institutions, and companies to maintain a powerful web of worldwide knowledge
Support internationalization efforts of Swiss academic institutions
Share innovative achievements and emerging trends in the host country and in Switzerland
Inform on developments in science, technology, education and innovation process
Participate in our communities and interact with Swiss and local partners to bring added value
The company markets a range of ethical pharmaceuticals and medical devices in more than 40 countries. They have a subsidiary in Hong Kong and are committed to growth in the international arena
Development of its own products in niche therapeutic areas (rheumatology, ophthalmology and neurology):
- Diacerein: the first and only oral IL-1 inhibitor for use in the treatment of osteoarthritis,
- Hyaluronic Acid: for intra-articular administration in the treatment of osteoarthritis,
- Vislube and Vismed lines: for topical ocular use as lubricants in the treatment of sensations of ocular dryness,
- Visiol: for intra-ocular use during ocular surgery.
- Drug for the treatment of Parkinson disease.
Springer and Adis products
Springer is a leading global publisher and publishes around 2000 journals and more than 4000 new books yearly. The Adis journals and newsletters and the three Adis databases are part of the Springer collection: Adis R&D Insight, Adis Clinical Trials Insight and Pharmacovigilance Insight.
With Springer for Research and Development Content Solutions, companies of all sizes can purchase and deliver Springer products tailored for their employee’s specific needs. Customizable purchase models and flexible pricing enable companies to select only the content that they require.
For instant access, reference materials, proven fixes and best practices, trusted, targeted information: rd.springer.com
Genscript is the leading gene, peptide, protein and antibody research partner for fundamental life science research, translational biomedical research, and early stage pharmaceutical development. Since our establishment in 2002, GenScript has exponentially grown to become a global leading Contract Research Organization that provide services and products to scientists in 86 countries worldwide. During our tenure we have built the best-in-class capacity and capability for biological research services encompassing gene synthesis and molecular biology, peptide synthesis, custom antibodies, protein expression, antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy.
Meissner Filtration Products, Inc.
Meissner develops, manufactures, supplies and services advanced microfiltration products and single-use systems worldwide. Meissner stands as a leader in microfiltration by providing high performance products and technical support services for critical applications.
Source: Biotech China